BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
67 results:

  • 1. Directing the migration of serum-free,
    Parwani KK; Branella GM; Burnham RE; Burnham AJ; Bustamante AYS; Foppiani EM; Knight KA; Petrich BG; Horwitz EM; Doering CB; Spencer HT
    Front Immunol; 2024; 15():1331322. PubMed ID: 38487542
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Deposition of onco-histone H3.3-G34W leads to DNA repair deficiency and activates cGAS/STING-mediated immune responses.
    Mancarella D; Ellinghaus H; Sigismondo G; Veselinov O; Kühn A; Goyal A; Hartmann M; Fellenberg J; Krijgsveld J; Plass C; Popanda O; Schmezer P; Bakr A
    Int J Cancer; 2024 Jun; 154(12):2106-2120. PubMed ID: 38353495
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia.
    Albinger N; Müller S; Kostyra J; Kuska J; Mertlitz S; Penack O; Zhang C; Möker N; Ullrich E
    Bone Marrow Transplant; 2024 Apr; 59(4):489-495. PubMed ID: 38253870
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy.
    Bachar-Lustig E; Lask A; Eidelstein Y; Or-Geva N; Gidron-Budovsky R; Nathansohn-Levy B; Eyrich M; Liu WH; Dang G; Miranda KC; Ramirez A; Kaur I; Rezvani K; Shpall E; Champlin RE; Nagler A; Shimoni A; Barnees-Kagan S; Reisner Y
    Transplant Cell Ther; 2024 Jan; 30(1):71.e1-71.e13. PubMed ID: 37890590
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of Cell Type-Specific Effects of
    Bae SG; Kim HJ; Kim MY; Kim DDH; Shin SI; Ahn JS; Park J
    Mol Cells; 2023 Oct; 46(10):611-626. PubMed ID: 37853686
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Lysine catabolism reprograms tumour immunity through histone crotonylation.
    Yuan H; Wu X; Wu Q; Chatoff A; Megill E; Gao J; Huang T; Duan T; Yang K; Jin C; Yuan F; Wang S; Zhao L; Zinn PO; Abdullah KG; Zhao Y; Snyder NW; Rich JN
    Nature; 2023 May; 617(7962):818-826. PubMed ID: 37198486
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Osteoprogenitor-gmp crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal.
    Hao X; Shen Y; Chen N; Zhang W; Valverde E; Wu L; Chan HL; Xu Z; Yu L; Gao Y; Bado I; Michie LN; Rivas CH; Dominguez LB; Aguirre S; Pingel BC; Wu YH; Liu F; Ding Y; Edwards DG; Liu J; Alexander A; Ueno NT; Hsueh PR; Tu CY; Liu LC; Chen SH; Hung MC; Lim B; Zhang XH
    Cell Stem Cell; 2023 May; 30(5):648-664.e8. PubMed ID: 37146584
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Manufacturing and validation of Good Manufacturing Practice-compliant regulatory dendritic cells for infusion into organ transplant recipients.
    Zahorchak AF; DeRiggi ML; Muzzio JL; Sutherland V; Humar A; Lakkis FG; Hsu YS; Thomson AW
    Cytotherapy; 2023 Apr; 25(4):432-441. PubMed ID: 36639251
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.
    Kekre N; Hay KA; Webb JR; Mallick R; Balasundaram M; Sigrist MK; Clement AM; Nielsen JS; Quizi J; Yung E; Brown SD; Dreolini L; Waller DD; Smazynski J; Gierc NS; Loveless BC; Clark K; Dyer T; Hogg R; McCormick L; Gignac M; Bell S; Chapman DM; Bond D; Yong S; Fung R; Lockyer HM; Hodgson V; Murphy C; Subramanian A; Wiebe E; Yoganathan P; Medynski L; Vaillan DC; Black A; McDiarmid S; Kennah M; Hamelin L; Song K; Narayanan S; Rodrigo JA; Dupont S; Hawrysh T; Presseau J; Thavorn K; Lalu MM; Fergusson DA; Bell JC; Atkins H; Nelson BH; Holt RA
    Front Immunol; 2022; 13():1074740. PubMed ID: 36601119
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characterization and Function of Cryopreserved bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft Source.
    Johnstone BH; Woods JR; Goebel WS; Gu D; Lin CH; Miller HM; Musall KG; Sherry AM; Bailey BJ; Sims E; Sinn AL; Pollok KE; Spellman S; Auletta JJ; Woods EJ
    Transplant Cell Ther; 2023 Feb; 29(2):95.e1-95.e10. PubMed ID: 36402456
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Brief Review of Radioactive Materials for Therapeutic and Diagnostic Purposes.
    Bharti M; Alam MA; Rao GSNK; Sharma PK
    Curr Radiopharm; 2023; 16(1):23-37. PubMed ID: 36306460
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lanthanide-Nucleotide Coordination Nanoparticles for STING Activation.
    Luo Z; Liang X; He T; Qin X; Li X; Li Y; Li L; Loh XJ; Gong C; Liu X
    J Am Chem Soc; 2022 Sep; 144(36):16366-16377. PubMed ID: 36037283
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [An exploratory clinical study of the efficacy and safety of tumor-infiltrating lymphocytes in the treatment of metastatic osteosarcoma].
    Wang CR; Kang M; Xu J; Lyu Y; Jiang YF; Sun MX; Zuo DQ; Shen JK; Ma XJ; Sun W; Hua YQ; Cai Z
    Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2421-2427. PubMed ID: 36000370
    [No Abstract]    [Full Text] [Related]  

  • 14. Pharmacologic Inhibition of nt5c2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia.
    Reglero C; Dieck CL; Zask A; Forouhar F; Laurent AP; Lin WW; Albero R; Miller HI; Ma C; Gastier-Foster JM; Loh ML; Tong L; Stockwell BR; Palomero T; Ferrando AA
    Cancer Discov; 2022 Nov; 12(11):2646-2665. PubMed ID: 35984649
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficient polymer nanoparticle-mediated delivery of gene editing reagents into human hematopoietic stem and progenitor cells.
    El-Kharrag R; Berckmueller KE; Madhu R; Cui M; Campoy G; Mack HM; Wolf CB; Perez AM; Humbert O; Kiem HP; Radtke S
    Mol Ther; 2022 Jun; 30(6):2186-2198. PubMed ID: 35240320
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Type-I Interferon Signaling in Fanconi Anemia.
    Landelouci K; Sinha S; Pépin G
    Front Cell Infect Microbiol; 2022; 12():820273. PubMed ID: 35198459
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combination of ultra-purified stem cells with an in situ-forming bioresorbable gel enhances intervertebral disc regeneration.
    Ukeba D; Yamada K; Suyama T; Lebl DR; Tsujimoto T; Nonoyama T; Sugino H; Iwasaki N; Watanabe M; Matsuzaki Y; Sudo H
    EBioMedicine; 2022 Feb; 76():103845. PubMed ID: 35085848
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Preclinical evaluation of [
    Estrada S; Elgland M; Selvaraju RK; Mani K; Tegler G; Wanhainen A; Wågsäter D; Bergström M; Jimenez-Royo P; Jahan M; Nordeman P; Antoni G
    Nucl Med Biol; 2022; 106-107():62-71. PubMed ID: 35066391
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Development of a cgmp-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells.
    Kim-Hoehamer YI; Riberdy JM; Zheng F; Park JJ; Shang N; Métais JY; Lockey T; Willis C; Akel S; Moore J; Meagher MM; Velasquez MP; Triplett BM; Talleur AC; Gottschalk S; Zhou S
    Gene Ther; 2023 Apr; 30(3-4):222-231. PubMed ID: 34997202
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparative analysis of the combined petrosal and the pretemporal transcavernous anterior petrosal approach to the petroclival region.
    Labib MA; Zhao X; Houlihan LM; Abramov I; Catapano JS; Naeem K; Preul MC; Youssef AS; Lawton MT
    J Neurosurg; 2022 Mar; 136(3):905-916. PubMed ID: 34507299
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.